Abstract:Background Alzheimer’s disease (AD) displays a long asymptomatic stage prior to development of dementia. Identification of molecular alterations during AD progression would provide insight into temporal alterations associated with AD. Method AD stage‐associated molecular networks were characterized by mass spectrometry in 90 frontal cortical tissue samples in five groups, including controls with low/high amyloid plaque and tau tangle pathology (LPC and HPC, respectively), cases with high Aβ pathology and slight mild cognitive impairment (MCI), late‐stage AD with high plaque/tangle pathology, and samples with progressive supranuclear palsy (PSP). We additionally performed whole proteome comparisons between human AD and the 5XFAD and Tau P301S mouse models. Protein targets implicated as altered by AD progression in the proteomic analyses were validated by affinity assays and immunostaining in human tissue and mouse models. Results AD stage‐associated molecular networks were characterized by profiling 14,513 proteins and 34,173 phosphosites in human brain with mass spectrometry, highlighting 173 protein alterations in 17 pathways. In total 16,128 proteins in 5xFAD and wild‐type mouse cortex were profiled, and share 97, 89, and 169 protein alterations with HPC, MCI, and AD, respectively, whereas Tau P301S mice share less than 15 protein alterations with each group. Neither mouse model shares more than 15 non‐tau phosphopeptide alterations with each AD sub‐group, although Tau P301S shares up to 78 phospho‐Tau peptides with human AD. During validation of proteins implicated in the proteome characterization, Netrin‐1 levels were found to increase in AD stage progression by immunoblotting but was not augmented in any other neurodegenerative disease cases tested. Additionally, affinity assays demonstrated a direct Aβ‐Netrin‐1 interaction, and immunostaining demonstrated Netrin‐1 and amyloid plaque colocalization in human AD and 5X‐FAD brain tissues, but not in Tau P301S. Conclusion Our proteomic analyses reveal altered proteins in AD and related mouse models. Human‐mouse comparisons suggest 5xFAD mice resemble symptomatic AD and that Tau P301S mice reproduce only AD‐related Tau phosphorylation. Netrin‐1 accumulates in AD, shows direct Aβ binding, and colocalizes with amyloid plaques in human AD and mouse 5XFAD brain tissue, and may be vital to AD pathogenesis. These results provide novel insights into AD‐associated proteins and pathways.

Investigation of early molecular alterations in tauopathy with generative adversarial networks

A practical application of generative adversarial networks for RNA-seq analysis to predict the molecular progress of Alzheimer's disease

Detection of individual brain tau deposition in Alzheimer's disease based on latent feature-enhanced generative adversarial network

Artificial intelligence in neuropathology: deep learning-based assessment of tauopathy

Advancing Diagnostic Performance and Clinical Applicability of Deep Learning-Driven Generative Adversarial Networks for Alzheimer's Disease.

TauFlowNet: Revealing latent propagation mechanism of tau aggregates using deep neural transport equations

Brain Status Transferring Generative Adversarial Network for Decoding Individualized Atrophy in Alzheimer's Disease

A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation

Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer's disease

Multimodal Neuroimaging Data in Early Detection of Alzheimer's Disease: Exploring the Role of Ensemble Models and GAN Algorithm

Cross-Modality Translation with Generative Adversarial Networks to Unveil Alzheimer's Disease Biomarkers

Potent of strategic approaches for tauopathies ranging from single-cell transcriptome to microbiome

Tau Protein Accumulation Trajectory-Based Brain Age Prediction in the Alzheimer's Disease Continuum

An Unsupervised Region of Interest Extraction Model for Tau PET Images and Its Application in the Diagnosis of Alzheimer's Disease.

A deep generative multimodal imaging genomics framework for Alzheimer's disease prediction

Generative AI unlocks PET insights: brain amyloid dynamics and quantification

Morphological Feature Visualization of Alzheimer's Disease via Multidirectional Perception GAN

Intelligent Alzheimer's Diseases Gene Association Prediction Model Using Deep Regulatory Genomic Neural Networks

Elucidating the neuropathological and molecular heterogeneity of amyloid-beta and tau in Alzheimer's disease through machine learning and transcriptomic integration

Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a knock-in tauopathy model

Deep multilayer brain proteomics identifies molecular networks and Netrin‐1 accumulation in Alzheimer’s disease progression: Genetics/omics and systems biology